Anacor skin cream succeeds in studies, fuels takeover expectations
(Reuters) - Anacor Pharmaceuticals Inc's experimental skin ointment succeeded in late-stage studies, taking the drugmaker a step closer to having a potential blockbuster in its portfolio and raising expectations that it could be taken over.